Lessee, Operating Lease, Liability, to be Paid, Year Three in USD of Inmune Bio, Inc. from Q2 2019 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Inmune Bio, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three history and change rate from Q2 2019 to Q4 2024.
  • Inmune Bio, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending 31 Dec 2024 was $51K, a 74.2% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Three, YoY Quarterly Change (%)

Inmune Bio, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $51K -$147K -74.2% 31 Dec 2024 10-K 27 Mar 2025
Q2 2024 $51K 30 Jun 2024 10-Q 01 Aug 2024
Q1 2024 $51K 31 Mar 2024 10-Q 09 May 2024
Q4 2023 $198K 31 Dec 2023 10-K 28 Mar 2024
Q4 2021 $51K 31 Dec 2021 10-Q 31 Oct 2024
Q3 2019 $51.5K 30 Sep 2019 10-Q 08 Nov 2019
Q2 2019 $51.5K 30 Jun 2019 10-Q 09 Aug 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.